Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2006 1
2007 1
2008 2
2010 2
2013 1
2014 7
2015 2
2016 2
2017 4
2018 6
2019 2
2020 3
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Predictors of autosomal dominant polycystic kidney disease progression.
Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, Rossetti S. Schrier RW, et al. Among authors: brosnahan g. J Am Soc Nephrol. 2014 Nov;25(11):2399-418. doi: 10.1681/ASN.2013111184. Epub 2014 Jun 12. J Am Soc Nephrol. 2014. PMID: 24925719 Free PMC article. Review.
Closeout of the HALT-PKD trials.
Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC. Moore CG, et al. Among authors: brosnahan g. Contemp Clin Trials. 2015 Sep;44:48-55. doi: 10.1016/j.cct.2015.07.017. Epub 2015 Jul 29. Contemp Clin Trials. 2015. PMID: 26231556 Free PMC article.
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP; HALT PKD Consortium. Bae KT, et al. Among authors: brosnahan g. J Am Soc Nephrol. 2020 Jul;31(7):1640-1651. doi: 10.1681/ASN.2019101121. Epub 2020 Jun 2. J Am Soc Nephrol. 2020. PMID: 32487558 Free PMC article.
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
Bae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZ; CRISP and HALT PKD Consortium. Bae KT, et al. Among authors: brosnahan g. Clin J Am Soc Nephrol. 2022 Mar;17(3):374-384. doi: 10.2215/CJN.08660621. Epub 2022 Feb 25. Clin J Am Soc Nephrol. 2022. PMID: 35217526 Free PMC article.
Bioactive lipid mediators in polycystic kidney disease.
Klawitter J, Klawitter J, McFann K, Pennington AT, Abebe KZ, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Gitomer B, Christians U, Schrier RW. Klawitter J, et al. Among authors: brosnahan g. J Lipid Res. 2014 Jun;55(6):1139-49. doi: 10.1194/jlr.P042176. Epub 2013 Dec 16. J Lipid Res. 2014. PMID: 24343898 Free PMC article. Clinical Trial.
PKD1 Compared With PK D2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.
Steele C, You Z, Gitomer BY, Brosnahan GM, Abebe KZ, Braun WE, Chapman AB, Harris PC, Perrone RD, Steinman TI, Torres VE, Yu ASL, Chonchol M, Nowak KL. Steele C, et al. Among authors: brosnahan gm. Kidney Int Rep. 2021 Oct 7;7(1):117-120. doi: 10.1016/j.ekir.2021.09.013. eCollection 2022 Jan. Kidney Int Rep. 2021. PMID: 35005320 Free PMC article. No abstract available.
35 results